Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments


QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAprep&amp CRISPR Kit and CRISPR Q-Primer Solutions that allow researchers to analyze edited genetic material with

IMV Announces Annual and Special Meeting of Shareholders Voting Results: https://mms.businesswire.com/media/20200225005324/en/775456/5/IMV_Logos_IMV-Logo_BrandStatement.jpg
IMV Announces Annual and Special Meeting of Shareholders Voting Results


IMV Inc. (“IMV” or the “Company”) (Nasdaq: IMV; TSX: IMV), a clinical-stage biopharmaceutical company, today announced the voting results from its annual and special meeting of shareholders held on

Humana Pharmacy Moves to Sustainable Packaging for Temperature-Sensitive Shipments: https://mms.businesswire.com/media/20210617005104/en/885772/5/Sustainable_Package_1.jpg
Humana Pharmacy Moves to Sustainable Packaging for Temperature-Sensitive Shipments


Humana Inc. (NYSE: HUM), a leading health and well-being company, has announced that Humana Pharmacy customers have started receiving temperature-sensitive medications in new

AMN Highest Ranked Healthcare MSP in Global HRO Today Customer Satisfaction Awards: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Highest Ranked Healthcare MSP in Global HRO Today Customer Satisfaction Awards


AMN Healthcare (NYSE: AMN), the leader and innovator in healthcare total talent services to facilities across the nation, achieved the highest ranking for a healthcare Managed Services Program in

ICON Announces Pricing of Senior Secured Notes: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Announces Pricing of Senior Secured Notes


ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (“PRA”) pursuant to which Indigo Merger Sub, Inc., a wholly owned

Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF): https://mms.businesswire.com/media/20200318005128/en/780378/5/BusinessWireLogo.jpg
Simulations Plus Releases IPFsym version 1A, State-of-the-Art Quantitative Systems Pharmacology (QSP) Software for Idiopathic Pulmonary Fibrosis (IPF)


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it has released IPFsym version

Premier Inc. Honors Florida Nonprofit Dedicated to Fighting Food Insecurity With National Award and $100,000 Prize: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. Honors Florida Nonprofit Dedicated to Fighting Food Insecurity With National Award and $100,000 Prize


Community Enhancement Collaboration, Inc. (CEC), a nonprofit dedicated to eradicating food insecurity in Broward County, Florida, has received the 28th annual Monroe E. Trout Premier Cares Award

Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumoniahttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Data Published in New England Journal of Medicine Shows Pfizer’s Tofacitinib Meets Primary Endpoint in Brazilian Study in Patients Hospitalized with COVID-19 Pneumonia


Pfizer Inc. (NYSE: PFE) and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive

THERANEXUS : MINUTES OF THE COMBINED GENERAL MEETING OF 16 JUNE 2021

The combined general meeting of shareholders was held on 16 June 2021 at 10:00 am at the Etoile Business Center, 21-25 rue Balzac, 75008 Paris.

The general meeting adopted all the resolutions by a

Pfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with Analystshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Invites Public to View and Listen to Webcast of Pfizer July 28 Conference Call with Analysts


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, July 28, 2021. The

Atrium Health Recognized for Innovation, High-Quality Healthcare by Premier Inc.: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Atrium Health Recognized for Innovation, High-Quality Healthcare by Premier Inc.


Premier Inc., a leading healthcare improvement company, (NASDAQ: PINC) has named Atrium Health, an integrated, nonprofit health system serving the Carolinas and Georgia, the winner of the 2021

CenterWell Senior Primary Care to Open Four Senior-Focused Care Centers in South Louisiana: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
CenterWell Senior Primary Care to Open Four Senior-Focused Care Centers in South Louisiana


CenterWell Senior Primary Care will open four new senior-focused care centers in South Louisiana by early 2022, giving seniors in Denham Springs, Hammond, Covington, Slidell and surrounding areas

Novocure Initiates Usability Study for Flexible Torso Array: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Initiates Usability Study for Flexible Torso Array


Novocure (NASDAQ: NVCR) today announced it has advanced a new, flexible torso array into a clinical usability study. The updated array will be tested by patients and their caregivers at four

ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting : https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Shareholders Vote in Favour of All Resolutions at its Extraordinary General Meeting


ICON plc (NASDAQ: ICLR) (“ICON”), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and

West Virginia PEIA Renews Humana as Health Insurer for Retirees: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
West Virginia PEIA Renews Humana as Health Insurer for Retirees


Humana Inc. (NYSE: HUM) has been awarded a new, four-year contract with the West Virginia Public Employee’s Insurance Agency (PEIA). As part of the contract, effective Jan. 1, 2022, Humana will

LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea: https://mms.businesswire.com/media/20191101005329/en/555341/5/LN-Logo-Main-PANTONE.jpg
LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea


LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to proceed with its

Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results: https://mms.businesswire.com/media/20210615005317/en/885147/5/Arc_Premier_QSM-R_FTN-R_CH-A_TUV_angled_1.jpg
Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results


Waters Corporation (NYSE:WAT) today introduced the Waters™ Arc™ Premier System, the first liquid chromatography system optimized for chromatographic separations on 2.5 – 3.5 micron columns to also

Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting: https://mms.businesswire.com/media/20191121005600/en/479704/5/Lantheus%C2%AE_Holdings_RGB.jpg
Lantheus To Present Piflufolastat F 18 Data at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2021 Annual Meeting


Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider committed to innovative imaging diagnostics, targeted therapeutics and artificial

Agilent Presents Thought Leader Award to Dr. Stéphane Bayen: https://mms.businesswire.com/media/20210614005189/en/884806/5/stephane_bayen.jpg
Agilent Presents Thought Leader Award to Dr. Stéphane Bayen


Agilent Technologies Inc. (NYSE: A) today announced that Stéphane Bayen has received an Agilent Thought Leader Award. Dr. Bayen is an Associate Professor in the Department of Food Science and

ICON Announces Private Offering of Senior Secured Notes: https://mms.businesswire.com/media/20191114005374/en/602293/5/ICON_Positive_logo_PNG_%28nostrap%29.jpg
ICON Announces Private Offering of Senior Secured Notes


ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc. (“PRA”) pursuant to which Indigo Merger Sub, Inc., a wholly owned

Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors: https://mms.businesswire.com/media/20210614005185/en/884788/5/BBalakrishnan_Jun21_headshot-approved.jpg
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (Aurinia or the Company) announced today the appointment of Dr. Brinda Balakrishnan, M.D., Ph.D., to the Company’s Board of Directors

Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device: https://mms.businesswire.com/media/20191114005606/en/588971/5/Quidel_Horiz_Sml_Vector_CMYK.jpg
Quidel Receives Amended Emergency Use Authorization for New Sofia® Q Rapid Antigen Test Device


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has

British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy: https://mms.businesswire.com/media/20210611005428/en/884476/5/DSC_2956_Edit.jpg
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy


Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), announced today that people with diabetes who are on intensive insulin therapy, age two years or older, may

Lysogene Enters into an Exclusive Worldwide License Agreement with SATT Conectus for a Gene Therapy Candidate for the Treatment of the Fragile X Syndrome


Regulatory News:



Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting central nervous system (CNS) diseases, today announces that it has entered into an

Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders: https://mms.businesswire.com/media/20191107005162/en/305545/5/Clovis_Logo_Process_Color.jpg
Clovis Oncology Announces Partial Adjournment of Annual Meeting of Stockholders


Clovis Oncology, Inc. (NASDAQ:CLVS) (the “Company”) today announced partial results and the partial adjournment of its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). The Company